Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marcus Paulo Fernandes Amarante"'
Publikováno v:
Case Reports in Clinical Pathology. 3
Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver, with approximately 10%-20% of the cases occurring in the non-cirrhotic liver. Hepatic adenomas (HA) are benign liver neoplasms, which arise predominantly in the settin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f2dfa12d15175320c03d90a1f6d1129
https://doi.org/10.5430/crcp.v3n1p1
https://doi.org/10.5430/crcp.v3n1p1
Autor:
Carina Meira Abrahão, Marcus Paulo Fernandes Amarante, Aline Da Rocha Lino, Marcelo Rocha de Sousa Cruz
Publikováno v:
ecancermedicalscience
Lung cancer is the leading cause of cancer death in the United States and other industrialised countries. The most important risk factor is active smoking. However, given the increased incidence of lung cancer in non-smokers, it is necessary to impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c63e081dab7ccf833a2d44554fcd641a
https://doi.org/10.3332/ecancer.2015.572
https://doi.org/10.3332/ecancer.2015.572
Autor:
Fernando C. Maluf, Jessica Ribeiro Gomes, Carolina Kawamura Haddad, Antonio C. Buzaid, Marcelo Rocha Cruz, Marcos André Costa, Rafael Schmerling, Tercia Tarciane Soares de Sousa, Renata D'Alpino D'Alpino, Fabio A.B. Schutz, Raphael Brandao Moreira, Marcus Paulo Fernandes Amarante
Publikováno v:
Journal of Clinical Oncology. 33:e12521-e12521
e12521 Background: Several patients with lung cancer (LC) maintain good performance status even after disease progression following all standard therapies. More recently, targeted therapies have be...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f99b86cacd19fe77b16572e84b0ff3e
https://doi.org/10.1200/jco.2015.33.15_suppl.e12521
https://doi.org/10.1200/jco.2015.33.15_suppl.e12521
Autor:
Jessica Ribeiro Gomes, Rafael Schmerling, Marcus Paulo Fernandes Amarante, Tercia Tarciane Soares de Sousa, Renata D'Alpino D'Alpino, Marcos André Costa, Fabio A.B. Schutz, Marcelo Rocha Cruz, Raphael Brandao Moreira, Aline Da Rocha Lino, Carolina Kawamura Haddad, Fernando C. Maluf, Antonio C. Buzaid
Publikováno v:
Journal of Clinical Oncology. 33:e19115-e19115
e19115 Background: Non-small cell lung cancer (NSCLC) is known to harbor molecular mutations or rearrangements predictive to a variety of targeted therapies, which have been increasing the overall ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a28ec5ff7cfbe071078a1bb47fbdf463
https://doi.org/10.1200/jco.2015.33.15_suppl.e19115
https://doi.org/10.1200/jco.2015.33.15_suppl.e19115
Autor:
Marcelo Rocha Cruz, Jessica Ribeiro Gomes, Tercia Tarciane Soares de Sousa, Renata D'Alpino D'Alpino, Marcos André Costa, Carolina Kawamura Haddad, Fernando C. Maluf, Rafael Schmerling, Antonio C. Buzaid, Marcus Paulo Fernandes Amarante, Raphael Brandao Moreira, Fabio A.B. Schutz
Publikováno v:
Journal of Clinical Oncology. 33:e22175-e22175
e22175 Background: Several patients with advanced cancer maintain good performance status even after disease progression following all standard therapies. Next-generation sequencing (NGS) is a powe...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3295e0337ff5ee90e7db9e7997c87d1
https://doi.org/10.1200/jco.2015.33.15_suppl.e22175
https://doi.org/10.1200/jco.2015.33.15_suppl.e22175
Autor:
Tercia Tarciane Soares de Sousa, Renata D'Alpino D'Alpino, Jessica Ribeiro Gomes, Fernando C. Maluf, Antonio C. Buzaid, Raphael Brandao Moreira, Marcus Paulo Fernandes Amarante, Aline Da Rocha Lino, Carolina Kawamura Haddad, Rafael Schmerling
Publikováno v:
Journal of Clinical Oncology. 33:e20073-e20073
e20073 Background: The long term survival impact of biochemotherapy (BioCT) for patients with metastatic melanoma (MM) is not well established in the literature. We performed a retrospective analys...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a9ad791ef65122d85cf56256cfbcfae
https://doi.org/10.1200/jco.2015.33.15_suppl.e20073
https://doi.org/10.1200/jco.2015.33.15_suppl.e20073
Autor:
Marcus Paulo Fernandes Amarante, Antonio C. Buzaid, Fernando C. Maluf, Marcos André Costa, Tercia Tarciane Soares de Sousa, Renata D'Alpino D'Alpino, Jessica Ribeiro Gomes, Marcelo Rocha Cruz, Raphael Brandao Moreira, Carolina Kawamura
Publikováno v:
Journal of Clinical Oncology. 33:e19069-e19069
e19069 Background: Brain metastasis (BM) are an event relatively frequent in the clinical course of patients with lung adenocarcinoma. Despite all advances in therapeutical approach, it still has a dismal prognosis. I Identifying subgroups with a hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d44b34bcdd6aaa53e65bf1ea7a10dc4b
https://doi.org/10.1200/jco.2015.33.15_suppl.e19069
https://doi.org/10.1200/jco.2015.33.15_suppl.e19069
Autor:
Raphael Brandao Moreira, Marcus Paulo Fernandes Amarante, Fernando C. Maluf, Antonio C. Buzaid, Marcos André Costa, Rafael Schmerling, Jessica Ribeiro Gomes, Carolina Kawamura, Tercia Tarciane Soares de Sousa, Renata D'Alpino D'Alpino
Publikováno v:
Journal of Clinical Oncology. 33:e21521-e21521
e21521 Background: Inoperable sarcoma may be associated with limiting local symptoms . To date, there are no data regarding the efficacy of palliative intra-arterial cisplatin for unresectable sarc...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38519d2e2a63c606ecc2a6752072993e
https://doi.org/10.1200/jco.2015.33.15_suppl.e21521
https://doi.org/10.1200/jco.2015.33.15_suppl.e21521
Autor:
Aline Da Rocha Lino, Carolina Kawamura Haddad, Tarcia Tarciane Soares de Sousa, Rafael Ferreira de Carvalho, Renata D'Alpino Peixoto, Marcus Paulo Fernandes Amarante, Fernando C. Maluf, Carina Mina Abrahao, Antonio C. Buzaid, Matheus Bongers Alessandretti, Coaem, Jessica Ribeiro Gomes, Fabio A.B. Schutz, Rodnei Merlrina Martins Junior, Raphael Brandao Moreira, Marcelo Rocha Cruz
Publikováno v:
Journal of Clinical Oncology. 33:72-72
72 Background: A considerable number of patients with mGIC progress after exhausting all approved standard therapies but maintain an adequate performance status and could be candidates for further treatment. We aim at reviewing our experience with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b7804dc65fbd98ac92bdea541230e2
https://doi.org/10.1200/jco.2015.33.3_suppl.72
https://doi.org/10.1200/jco.2015.33.3_suppl.72
Autor:
Pedro Zanuncio, Rafael Ferreira de Carvalho, Fernando C. Maluf, Antonio C. Buzaid, Marcelo Rocha Cruz, Robson Ferrigno, Raphael Brandao Moreira, Marcus Paulo Fernandes Amarante, Paulo Moraes, Renata D'Alpino Peixoto, Erlon Gil
Publikováno v:
Journal of Clinical Oncology. 33:458-458
458 Background: FOLFIRINOX was found to have higher response rates and overall survival (OS) compared to gemcitabine-based regimens in the metastatic setting. However, the contribution of chemoradiotherapy to outcomes after FOLFIRINOX in LAPC remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dff366b048a05868b2aaa98072f50b9
https://doi.org/10.1200/jco.2015.33.3_suppl.458
https://doi.org/10.1200/jco.2015.33.3_suppl.458